Silvercrest Asset Management Group LLC Novo Cure LTD Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q2 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 540,297 shares of NVCR stock, worth $7.59 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
540,297
Previous 458,028
17.96%
Holding current value
$7.59 Million
Previous $8.16 Million
17.83%
% of portfolio
0.07%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding NVCR
# of Institutions
284Shares Held
77.5MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$170 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$151 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$97 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$89.7 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$37.6 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.47B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...